// Neurotoxin

Jeuveau

Jeuveau (PrabotulinumtoxinA-xvfs)

FDA-approved botulinum toxin originally developed for cosmetic indications. Used for the same dynamic-line indications as Botox — glabella, forehead, lateral canthi — often at a comparable per-unit cost.

What it is

Jeuveau (PrabotulinumtoxinA-xvfs) is FDA-approved botulinum toxin type A, developed specifically for cosmetic indications. Mechanism is the same as Botox; clinical onset and duration are broadly comparable, with some patients reporting faster onset.

How we approach it

The injector calibrates dose per area based on your prior response and the published Jeuveau conversion ratios. For established neurotoxin patients curious about alternatives, Jeuveau is a reasonable comparison product.

What to expect

Onset two to five days. Full effect at seven to fourteen days. Duration three to four months. Post-treatment care identical to other neurotoxins.

Candidacy

Good for established neurotoxin patients who want to compare products, or for cost-sensitive patients seeking dynamic-line softening. Not for pregnant or nursing patients or those with neuromuscular disease.

Indicated for

  • Dynamic glabellar lines (between the brows)
  • Patients seeking conservative cosmetic neurotoxin with a faster onset profile
  • Established neurotoxin patients open to comparing products

Not a candidate if

  • Pregnant or nursing patients
  • Patients with neuromuscular disease
  • First-time neurotoxin patients who would benefit from a more established starting agent

Before your visit

  • Dose conversions from Botox are roughly 1:1 in current practice
  • Onset can be faster than Botox for some patients; full effect at one to two weeks
  • Post-treatment care identical to other neurotoxins — no lying flat for four hours, no hard exercise for 24

Begin with the consultation.

Every plan is drawn before it is performed. The team trains under Dr. Brown.

Book a Consultation View all treatments